The SPG11 gene helps nerve cells, especially those with long connections in the brain and spinal cord, clear waste and stay healthy. When both copies carry harmful variants, these nerve cells may gradually stop working, which can lead to an inherited condition called spastic paraplegia, often with leg stiffness, weakness, and trouble walking, and sometimes changes in speech, thinking, or hand use. Some people with SPG11-related disease also develop a broader nerve condition, including juvenile-onset amyotrophic lateral sclerosis (ALS).
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the instructions for making proteins, the parts of cells that do the work. Others mainly regulate when certain processes happen, where they happen, and how strongly they take place. As a group, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can read more in the LearnHub.
Overview
SPG11Gene function
What if the gene works
The SPG11 gene helps nerve cells recycle worn-out cell material and maintain long cell branches called axons. This supports healthy communication between the brain, spinal cord, and muscles.
Risk
What if the gene does not work
Pathogenic variants in the SPG11 gene usually cause hereditary spastic paraplegia, with increasing leg stiffness and weakness, often with balance, bladder, or thinking changes. Effects can range from milder to more severe, and some people also develop other nerve problems.
Treatment
What does that mean for your treatment
No SPG11-specific treatment or drug choice is currently established for pathogenic variants in the SPG11 gene. The SPG11 gene is being studied in early-stage research as a possible source of treatment targets, especially pathways involved in nerve cell waste clearance and lysosome function.
Conditions associated with SPG11
Gene function
What if the gene works
Long nerve cells rely on the SPG11 gene for steady day to day upkeep. It helps cells move and recycle materials, especially through the lysosome, the cell’s cleanup and recycling compartment. Understanding how the SPG11 gene works can make it easier to see how nerve cells stay organized over time.
The SPG11 gene helps cells process worn out parts and used materials through autophagy, a built in recycling pathway. This supports routine cell cleanup and helps keep the inside of the cell orderly.
Its protein, spatacsin, helps the lysosome reform after recycling work is underway. This allows the cell’s recycling compartment to be reused for the next round of cleanup.
The SPG11 gene supports membrane traffic, which is the movement of small sacs and materials inside cells. In long nerve cells, this helps keep supplies moving to places that need them.
Long nerve cells need regular maintenance because they extend over long distances in the body. The SPG11 gene helps support this ongoing upkeep, especially along the axon, the long part of a nerve cell that carries signals.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human differences, such as appearance, metabolism, and the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SPG11 gene stop cells from making a full spatacsin protein or leave it unstable, which disrupts lysosome recycling (the cell’s waste handling system) and related transport inside nerve cells. In how SPG11 gene variants affect protein function, more severe variants often leave little or no working protein, while milder variants may preserve some activity. This difference can influence how early SPG11-related nerve disease begins and how strongly it affects movement.
How variants are linked to conditions
Pathogenic variants in the SPG11 gene most often cause hereditary spastic paraplegia type 11, an inherited condition marked by gradually increasing leg stiffness and walking difficulty. SPG11 gene variants and hereditary spastic paraplegia are closely linked in genetic testing, usually when both copies of the gene carry a pathogenic variant. Some people with SPG11-related disease also have changes in thinking, nerve symptoms, or juvenile amyotrophic lateral sclerosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SPG11, risk is mainly set by the variants you inherit rather than by lifestyle. The chance is higher in families where both parents carry an SPG11 variant, and it can also be higher when parents are blood relatives. There is not enough evidence to say that diet, exercise, or other daily habits lower the chance of developing an SPG11-related condition.
Inheritance of SPG11 variants
For most people reading about the SPG11 inheritance pattern, the key point is that SPG11-related conditions are usually inherited in an autosomal recessive way. This means a person typically inherits one SPG11 gene variant from each parent. Parents who each carry one variant usually do not have the condition themselves, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. Because the SPG11 gene is on chromosome 15, this pattern is the same for males and females.
What does my SPG11 result mean for my family?
For SPG11-related conditions, the family pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, so close relatives can sometimes learn useful information from family testing. Children of someone with an SPG11-related condition will usually be carriers, and the chance of an affected child depends on whether the other parent also carries an SPG11 change.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SPG11 gene, doctors use a blood or saliva sample for genetic testing for hereditary spastic paraplegia. A lab reads the gene's DNA code and checks for variants, often as part of a larger nerve disease panel or an exome test. Results may show whether an SPG11 variant helps explain symptoms or carrier status.
When should I consider getting a genetic test?
Consider SPG11 genetic testing if you or your child has a slowly worsening nerve condition with leg stiffness, weakness, balance problems, or trouble walking, especially when it starts in childhood or early adult life. Testing can also help when close relatives have a similar inherited condition.
A genetic result is only one part of your health story
A genetic finding can be informative, but the amount it reveals depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result can offer a straightforward answer. In areas like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug. This helps explain why the same treatment works well for one person, has less effect for another, or causes more side effects in someone else. These differences are common and can influence both how well a medicine works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It looks at links between genes and drugs to help explain why the same treatment may work differently in different people. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SPG11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
Families and communities once noticed patterns that seemed to pass from parent to child, but the history of the SPG11 gene became clearer through modern neurology and genetics. In the 1990s, doctors carefully described families with inherited leg stiffness and weakness, often together with a thin corpus callosum, a brain structure seen on scans. From these first observations, research expanded steadily. In the mid 2000s, scientists mapped the cause in many of these families to the SPG11 gene, making it one of the best known genes linked to this form of hereditary spastic paraplegia. As more people were studied, the clinical picture widened, and SPG11 was also recognized in some related nerve conditions. These historical steps shaped today’s understanding.